Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has ...

Early Wednesday, on the second day of early voting in Georgia, I saw numerous elderly people on walkers and using canes to cast their ballots in DeKalb County. Some of them made use of the curb ...

DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...

She’s also a career coach and leadership consultant at Drayton Leadership Group, LLC. She alleges she was stripped of job ...

European stocks closed higher on Thursday as an interest rate cut by the Bank of England (BoE), and some encouraging earnings updates ...

Spyros Papapetropoulos, M.D., Ph.D., President and CEO of Bionomics, will deliver a company presentation during the Neuroscience Spotlight session taking place on Tuesday, November 12 at 1:00 p.m. ET ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

After holding firm till around mid afternoon on Wednesday, European stocks pared gains and closed weak as investors assessed the ...

Portfolio Receipts growth of 15% to $735 million; Royalty Receipts growth of 15%Net cash provided by operating activities of $704 millionCapital ...

Ripple effects from Polsinelli's 47-lawyer group move this summer are still generating benefits for the firm on the lateral ...

4BIO Capital (‘4BIO’) is an international venture capital firm headquartered in London, focused solely on the advanced and emerging therapies sector. The 4BIO team, which has an unrivalled network ...